At this stop on Pharma's Almanac's Road to 50 States trans-American roadtrip, Anthony Costa, CEO of Diant Pharma, talks to Nigel about how the company is innovating the nanoparticle space.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
DIANT Pharma was founded in 2019 and has developed a continuous processing technology applicable for nanoparticle drug products and vaccines. We strive to offer a technology that is robust and reliable from R&D to manufacturing; over a product’s lifespan.
Our proprietary continuous manufacturing system for nanoparticles has a wide array of applications within the pharmaceutical space.
.svg)
